BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34717620)

  • 1. Recombinant expression of insoluble enzymes in Escherichia coli: a systematic review of experimental design and its manufacturing implications.
    Mital S; Christie G; Dikicioglu D
    Microb Cell Fact; 2021 Oct; 20(1):208. PubMed ID: 34717620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology.
    Gatti-Lafranconi P; Natalello A; Ami D; Doglia SM; Lotti M
    FEBS J; 2011 Jul; 278(14):2408-18. PubMed ID: 21569207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic transcriptional response of Escherichia coli to inclusion body formation.
    Baig F; Fernando LP; Salazar MA; Powell RR; Bruce TF; Harcum SW
    Biotechnol Bioeng; 2014 May; 111(5):980-99. PubMed ID: 24338599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in
    Hashemzadeh MS; Mohammadi M; Ghaleh HEG; Sharti M; Choopani A; Panda AK
    Protein Pept Lett; 2021; 28(2):122-130. PubMed ID: 32729411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method for enhancing solubility of the expressed recombinant proteins in Escherichia coli.
    Ghosh S; Rasheedi S; Rahim SS; Banerjee S; Choudhary RK; Chakhaiyar P; Ehtesham NZ; Mukhopadhyay S; Hasnain SE
    Biotechniques; 2004 Sep; 37(3):418, 420, 422-3. PubMed ID: 15470897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
    Panda AK
    Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in refolding of proteins produced in E. coli.
    Lilie H; Schwarz E; Rudolph R
    Curr Opin Biotechnol; 1998 Oct; 9(5):497-501. PubMed ID: 9821278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
    Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin.
    Sharma A; Chaudhuri TK
    Microb Cell Fact; 2017 Oct; 16(1):173. PubMed ID: 28982367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method for Inclusion Bodies Production via E. coli Host System: rGCSF as Model Biotherapeutic Protein.
    Rani AK; Naira VR; Rathore AS
    Methods Mol Biol; 2023; 2617():249-256. PubMed ID: 36656530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New properties of inclusion bodies with implications for biotechnology.
    Peternel S; Jevsevar S; Bele M; Gaberc-Porekar V; Menart V
    Biotechnol Appl Biochem; 2008 Apr; 49(Pt 4):239-46. PubMed ID: 17708747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in heterologous protein production in Escherichia coli.
    Hockney RC
    Trends Biotechnol; 1994 Nov; 12(11):456-63. PubMed ID: 7765545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient in vitro refolding of recombinant bacterial laccase in Escherichia coli.
    Mollania N; Khajeh K; Ranjbar B; Rashno F; Akbari N; Fathi-Roudsari M
    Enzyme Microb Technol; 2013 May; 52(6-7):325-30. PubMed ID: 23608500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization of Escherichia coli recombinant proteins from inclusion bodies.
    Simpson RJ
    Cold Spring Harb Protoc; 2010 Sep; 2010(9):pdb.prot5485. PubMed ID: 20810632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of recombinant serpins in Escherichia coli.
    Bird PI; Pak SC; Worrall DM; Bottomley SP
    Methods; 2004 Feb; 32(2):169-76. PubMed ID: 14698629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical treatment of Escherichia coli: 3. Selective extraction of a recombinant protein from cytoplasmic inclusion bodies in intact cells.
    Falconer RJ; O'Neill BK; Middelberg AP
    Biotechnol Bioeng; 1999 Feb; 62(4):455-60. PubMed ID: 9921154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput recovery of therapeutic proteins from the inclusion bodies of Escherichia coli: an overview.
    Panda AK
    Methods Mol Biol; 2005; 308():155-61. PubMed ID: 16082033
    [No Abstract]   [Full Text] [Related]  

  • 19. Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.
    Wurm DJ; Quehenberger J; Mildner J; Eggenreich B; Slouka C; Schwaighofer A; Wieland K; Lendl B; Rajamanickam V; Herwig C; Spadiut O
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):667-676. PubMed ID: 29159587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian membrane receptors expression as inclusion bodies in Escherichia coli.
    Mouillac B; Banères JL
    Methods Mol Biol; 2010; 601():39-48. PubMed ID: 20099138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.